NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

OPKO Health Inc (TA: OPK)

 
OPK Technical Analysis
2
As on 25th Dec 2024 OPK STOCK Price closed @ 552.00 and we RECOMMEND Buy for LONG-TERM with Stoploss of 528.16 & Strong Sell for SHORT-TERM with Stoploss of 700.42 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

OPKSTOCK Price

Open 551.60 Change Price %
High 559.50 1 Day -1.70 -0.31
Low 550.00 1 Week -22.20 -3.87
Close 552.00 1 Month -87.00 -13.62
Volume 118171 1 Year -236.00 -29.95
52 Week High 800.00 | 52 Week Low 317.10
 
TA Israel Most Active Stocks
TA125 2008.05 1.06%
FRSX 27.50 5.77%
BONS 11.30 -0.88%
CANF 1.80 -5.26%
XTLB 6.50 10.17%
ORL 93.70 -0.32%
PPBT 6.80 -5.56%
KTOV 6.80 -2.86%
APLY 72.00 7.95%
ARDM 72.00 8.43%
 
TA Israel Top Gainers Stocks
TDGN-L 171.50 17.55%
NALA 699.00 11.84%
SEFA 699.00 11.84%
SEFA 699.00 11.84%
QNCO 750.00 11.11%
CNMD 45.10 10.54%
CNMD 45.10 10.54%
XTLB 6.50 10.17%
XTLB 6.50 10.17%
CSURE 990.00 10.00%
 
TA Israel Top Losers Stocks
KMNK 51.00 -23.19%
ULTR 74.10 -16.74%
NFTA 2258.00 -13.25%
MEAT 0.77 -9.41%
MEAT 0.77 -9.41%
PLAZ 136.00 -9.33%
PLAZ 136.00 -9.33%
SVRT 400.00 -9.09%
EDRL 14.30 -8.92%
MYSZ 153.90 -8.66%
 
 
OPK
Daily Charts
OPK
Intraday Charts
Whats New @
Bazaartrend
OPK
Free Analysis
 
OPK Important Levels Intraday
RESISTANCE570.31
RESISTANCE564.44
RESISTANCE560.81
RESISTANCE557.18
SUPPORT546.82
SUPPORT543.19
SUPPORT539.56
SUPPORT533.69
 
OPK Forecast December 2024
4th UP Forecast757.61
3rd UP Forecast691.67
2nd UP Forecast650.91
1st UP Forecast610.15
1st DOWN Forecast493.85
2nd DOWN Forecast453.09
3rd DOWN Forecast412.33
4th DOWN Forecast346.39
 
OPK Weekly Forecast
4th UP Forecast668.97
3rd UP Forecast631.46
2nd UP Forecast608.27
1st UP Forecast585.08
1st DOWN Forecast518.92
2nd DOWN Forecast495.73
3rd DOWN Forecast472.54
4th DOWN Forecast435.03
 
OPK Forecast2024
4th UP Forecast1542.48
3rd UP Forecast1224.83
2nd UP Forecast1028.48
1st UP Forecast832.13
1st DOWN Forecast271.87
2nd DOWN Forecast75.52
3rd DOWN Forecast-120.83
4th DOWN Forecast-438.48
 
 
OPK Other Details
Segment EQ
Market Capital 790830252032.00
Sector Healthcare
Industry Diagnostics & Research
Offical website >
 
OPK Address
OPK
 
OPK Latest News
 
Your Comments and Response on OPKO Health Inc
 
OPK Business Profile
OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare to physician offices, clinics, hospitals, employers and governmental units, as well as 4Kscore prostate cancer testing services. The company's Pharmaceutical segment offers Rayaldee for treatment for secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease, and vitamin D insufficiency; OPK88004, an orally administered selective androgen receptor modulator; OPK88003, a once-weekly administered peptide for the treatment of type 2 diabetes and associated obesity that is in Phase IIb trials; and hGH-CTP, a once-weekly human growth hormone injection that completed Phase III clinical trial in partnership with Pfizer, Inc. This segment develops and commercializes longer-acting proprietary versions of already approved therapeutic proteins. It also specialty active pharmaceutical ingredients; develops, manufactures, markets, and sells pharmaceutical, nutraceutical, veterinary, and ophthalmic products; commercializes food supplements and over the counter products; manufactures and sells products primarily in the generics market; and imports, markets, distributes, and sells pharmaceutical products in a range of indications, including cardiovascular products, vaccines, antibiotics, gastro-intestinal products, hormones, and others. In addition, the company operates pharmaceutical platforms in Ireland, Chile, Spain, and Mexico. OPKO Health, Inc. was incorporated in 1991 and is headquartered in Miami, Florida. Address: 4400 Biscayne Boulevard, Miami, FL, United States, 33137
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service